Job offersmore »

Tweeting Growers

Top 5 - yesterday

  • No news has been published yesterday.

Top 5 - last week

Top 5 - last month

Exchange ratesmore »

Australia: The Hydroponics Company appoints CCO

The Hydroponics Company has appointed Mrs Debbie Ormsby as Chief Commercial Officer. Mrs. Ormsby brings significant pharmaceutical and biotech expertise with extensive experience in end to end product commercialisation within the pharmaceutical markets. Her career spans a variety of senior leadership positions at a country, regional and global level including Managing Director, Meda Pharmaceuticals, General Manager, The Medicines Company, Regional Medical Director, Actelion Pharmaceuticals and Global Study Leader roles for both Roche Products and The Wellcome Foundation. Mrs. Ormsby is a trained pharmacist and a registered member of The Royal Pharmaceutical Society and expects to complete her MBA (Executive) from the AGSM in 2018.

In 2016 Mrs Ormsby undertook a consulting assignment assessing the global medicinal cannabis market and provided strategic advice which supported the subsequent legislation of medicinal cannabis in Victoria.

Mrs Ormsby stated she is excited to join THC at this stage of rapid expansion into the growing Australian market and looks forward to leveraging her pharmaceutical industry experience to facilitate patient access to medicinal cannabis for therapeutic use. Her goal is to focus on the objectives and priorities of the company that will achieve optimal results for all stakeholders and make a meaningful difference to the lives of Australian patients.

THC’s Group Chief Executive Officer, David Radford said: “We are delighted to have an executive of Debbie’s calibre with her impressive track record and enormous commercial experience join THC. Her career in the development of pharmaceutical markets both locally and internationally bring the required skills to help THC develop innovative solutions that bring the prescribing physicians and patients together to facilitate the access to high quality medicinal cannabis solutions."

For more information:
The Hydroponics Company
Suite 305, Level 3, 35 Lime Street
Sydney, NSW 2000 Australia

Publication date: 11/28/2017



Other news in this sector:

3/16/2018 US: Indoor Harvest forms scientific advisory board
3/15/2018 CAN (ON): Job growth skyrockets as MJ industry ramps up
3/14/2018 CAN (ON): Aphria adds 200,000 sq.ft. to triple production
3/13/2018 CAN (NL): Canopy Growth secures cannabis site
3/12/2018 Jamaica's first legal MMJ facility opens
3/12/2018 US (CA): Calaveras County MMJ growers face ban
3/9/2018 US (CA): MMJ sales are escalating, along with growers' energy costs
3/9/2018 Meet Canada's marijuana moguls
3/8/2018 "America is giving away the $30 billion medical marijuana industry"
3/8/2018 Prepping the largest cannabis grow in Canada
3/8/2018 US (WA): 28,000 sq.ft. MMJ facility nears completion
3/7/2018 UN report reveals UK is world’s biggest producer of medical cannabis
3/7/2018 "There really is no such thing as medical marijuana"
3/6/2018 CAN (BC): Village Farms starts 1.1 million sq.ft. cannabis cultivation
3/5/2018 CAN (BC): 26,000 sq.ft. MMJ greenhouse planned on Gabriola Island
3/2/2018 US (ME): 35,000 sq.ft. MMJ farm for sale
3/2/2018 Australia: MMJ grower educates doctors
3/2/2018 US (FL): MMJ grower expects to make $3 million from 10-acre greenhouse
3/1/2018 US (NV): Marapharm finalizes installations in Las Vegas
2/28/2018 Lesotho-based MMJ grower to export to Canada